A Phase I Clinical Trial to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2" in Healthy Adult Volunteers
Latest Information Update: 05 Feb 2024
At a glance
- Drugs BR 6001 (Primary)
- Indications Duodenal ulcer; Gastric cancer
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
Most Recent Events
- 18 Dec 2023 New trial record